Assessment of the Nicotine Pharmacokinetics When Using Two Types of E-Cigarettes in Healthy Adults Who Smoke: Results From Two Randomized, Crossover Studies

1. U.S. Department of Health and Human Services (DHHS), Centers for Disease Control and Prevention (CDC), National Center for Chronic Desease Prevention and Health Promotion, and Office on Smoking and Health: The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General; DHHS, Atlanta, GA, USA, 2014, 943 p. Available at: https://www.ncbi.nlm.nih.gov/books/NBK179276/pdf/Bookshelf_NBK179276.pdf (accessed June 2024) U.S. Department of Health and Human Services (DHHS), Centers for Disease Control and Prevention (CDC), National Center for Chronic Desease Prevention and Health Promotion, and Office on Smoking and Health The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General DHHS Atlanta, GA, USA 2014 943 Available at: https://www.ncbi.nlm.nih.gov/books/NBK179276/pdf/Bookshelf_NBK179276.pdf (accessed June 2024) Search in Google Scholar

2 Institute of Medicine (IOM): Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction; edited by K. Stratton, P. Shetty, et al., National Academies Press, Washington, DC, USA, 2001, 656 p., ISBN: 978-0-309-07282-3. Institute of Medicine (IOM) Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction edited by StrattonK. ShettyP. National Academies Press Washington, DC, USA 2001 656 978-0-309-07282-3 Search in Google Scholar

3. Dinakar, C. and G.T. O’Connor: The Health Effects of Electronic Cigarettes; N. Engl. J. Med. 375 (2016) 1372–1381. DOI: 10.1056/NEJMra1502466 DinakarC. O’ConnorG.T. The Health Effects of Electronic Cigarettes N. Engl. J. Med. 375 2016 1372 1381 10.1056/NEJMra1502466 Open DOISearch in Google Scholar

4. McNeill, A., L.S. Brose, R. Calder, L. Bauld, and D. Robson: Evidence Review of E-Cigarettes and Heated Tobacco Products 2018: A Report Commissioned by Public Health England. 2018; Public Health England, London, UK, 2018, pp. 1–243. McNeillA. BroseL.S. CalderR. BauldL. RobsonD. Evidence Review of E-Cigarettes and Heated Tobacco Products 2018: A Report Commissioned by Public Health England 2018 Public Health England London, UK 2018 1 243 Search in Google Scholar

5. Goniewicz, M.L., C.R. Miller, E. Sutanto, and D. Li: How Effective Are Electronic Cigarettes for Reducing Respiratory and Cardiovascular Risk in Smokers? A Systematic Review; Harm Reduct. J. 17 (2020) 91. DOI: 10.1186/s12954-020-00440-w GoniewiczM.L. MillerC.R. SutantoE. LiD. How Effective Are Electronic Cigarettes for Reducing Respiratory and Cardiovascular Risk in Smokers? A Systematic Review Harm Reduct. J. 17 2020 91 10.1186/s12954-020-00440-w Open DOISearch in Google Scholar

6. Akiyama, Y. and N. Sherwood: Systematic Review of Biomarker Findings from Clinical Studies of Electronic Cigarettes and Heated Tobacco Products; Toxicol. Rep. 8 (2021) 282–294. DOI: 10.1016/j.toxrep.2021.01.014 AkiyamaY. SherwoodN. Systematic Review of Biomarker Findings from Clinical Studies of Electronic Cigarettes and Heated Tobacco Products Toxicol. Rep. 8 2021 282 294 10.1016/j.toxrep.2021.01.014 Open DOISearch in Google Scholar

7. Kanobe, M.N., P.R. Nelson, B.G. Brown, P. Chen, P. Makena, J.W. Caraway, G.L. Prasad, and E.K. Round: Changes in Biomarkers of Exposure and Potential Harm in Smokers Switched to Vuse Vibe or Vuse Ciro Electronic Nicotine Delivery Systems; Toxics 11 (2023) 564. DOI: 10.3390/toxics11070564 KanobeM.N. NelsonP.R. BrownB.G. ChenP. MakenaP. CarawayJ.W. PrasadG.L. RoundE.K. Changes in Biomarkers of Exposure and Potential Harm in Smokers Switched to Vuse Vibe or Vuse Ciro Electronic Nicotine Delivery Systems Toxics 11 2023 564 10.3390/toxics11070564 Open DOISearch in Google Scholar

8. Fearon, I.M., A.C. Eldridge, N. Gale, M. McEwan, M.F. Stiles, and E.K. Round: Nicotine Pharmacokinetics of Electronic Cigarettes: A Review of the Literature; Regul. Toxicol. Pharmacol. 100 (2018) 25–34. DOI: 10.1016/j.yrtph.2018.09.004 FearonI.M. EldridgeA.C. GaleN. McEwanM. StilesM.F. RoundE.K. Nicotine Pharmacokinetics of Electronic Cigarettes: A Review of the Literature Regul. Toxicol. Pharmacol. 100 2018 25 34 10.1016/j.yrtph.2018.09.004 Open DOISearch in Google Scholar

9. DeVito, E.E. and S. Krishnan-Sarin: E-Cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure; Curr. Neuropharmacol. 16 (2018) 438–459. DOI: 10.2174/1570159X15666171016164430 DeVitoE.E. Krishnan-SarinS. E-Cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure Curr. Neuropharmacol. 16 2018 438 459 10.2174/1570159X15666171016164430 Open DOISearch in Google Scholar

10. Voos, N., M.L. Goniewicz, and T. Eissenberg: What Is the Nicotine Delivery Profile of Electronic Cigarettes?; Expert Opin. Drug Deliv. 16 (2019) 1193–1203. DOI: 10.1080/17425247.2019.1665647 VoosN. GoniewiczM.L. EissenbergT. What Is the Nicotine Delivery Profile of Electronic Cigarettes? Expert Opin. Drug Deliv. 16 2019 1193 1203 10.1080/17425247.2019.1665647 Open DOISearch in Google Scholar

11. Jacobson, K., J. Martinez, S. Larroque, I.W. Jones, and T. Paschke: Nicotine Pharmacokinetics of Electronic Cigarettes: A Pooled Data Analysis from the Literature; Toxicol. Rep. 8 (2020) 84–95. DOI: 10.1016/j.toxrep.2020.12.016 JacobsonK. MartinezJ. LarroqueS. JonesI.W. PaschkeT. Nicotine Pharmacokinetics of Electronic Cigarettes: A Pooled Data Analysis from the Literature Toxicol. Rep. 8 2020 84 95 10.1016/j.toxrep.2020.12.016 Open DOISearch in Google Scholar

12. Fearon, I.M., K. Gilligan, R.G.N. Seltzer, and W. McKinney: A Randomised, Crossover, Clinical Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the Bidi^® Stick ENDS Compared with Combustible Cigarettes and a Comparator ENDS in Adult Smokers; Harm Reduct. J. 19 (2022) 57. DOI: 10.1186/s12954-022-00638-0 FearonI.M. GilliganK. SeltzerR.G.N. McKinneyW. A Randomised, Crossover, Clinical Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the Bidi^® Stick ENDS Compared with Combustible Cigarettes and a Comparator ENDS in Adult Smokers Harm Reduct. J. 19 2022 57 10.1186/s12954-022-00638-0 Open DOISearch in Google Scholar

13. Goniewicz, M.L., T. Kuma, M. Gawron, J. Knysak, and L. Kosmider: Nicotine Levels in Electronic Cigarettes; Nicotine Tob. Res. 15 (2013) 158–166. DOI: 10.1093/ntr/nts103 GoniewiczM.L. KumaT. GawronM. KnysakJ. KosmiderL. Nicotine Levels in Electronic Cigarettes Nicotine Tob. Res. 15 2013 158 166 10.1093/ntr/nts103 Open DOISearch in Google Scholar

14. Farsalinos, K.E., G. Romagna, D. Tsiapras, S. Kyrzopoulos, and V. Voudris: Evaluation of Electronic Cigarette Use (Vaping) Topography and Estimation of Liquid Consumption: Implications for Research Protocol Standards Definition and for Public Health Authorities’ Regulation; Int. J. Environ. Res. Public Health 10 (2013) 2500–2514. DOI: 10.3390/ijerph10062500 FarsalinosK.E. RomagnaG. TsiaprasD. KyrzopoulosS. VoudrisV. Evaluation of Electronic Cigarette Use (Vaping) Topography and Estimation of Liquid Consumption: Implications for Research Protocol Standards Definition and for Public Health Authorities’ Regulation Int. J. Environ. Res. Public Health 10 2013 2500 2514 10.3390/ijerph10062500 Open DOISearch in Google Scholar

15. Hajek, P., M.L. Goniewicz, A. Phillips, K. Myers Smith, O. West, and H. McRobbie: Nicotine Intake from Electronic Cigarettes on Initial Use and after 4 Weeks of Regular Use; Nicotine Tob. Res. 17 (2015) 175–179. DOI: 10.1093/ntr/ntu153 HajekP. GoniewiczM.L. PhillipsA. Myers SmithK. WestO. McRobbieH. Nicotine Intake from Electronic Cigarettes on Initial Use and after 4 Weeks of Regular Use Nicotine Tob. Res. 17 2015 175 179 10.1093/ntr/ntu153 Open DOISearch in Google Scholar

16. St Helen, G., D.A. Dempsey, C.M. Havel, P. Jacob III, and N.L. Benowitz: Impact of E-Liquid Flavors on Nicotine Intake and Pharmacology of E-Cigarettes; Drug Alcohol Depend. 178 (2017) 391–398. DOI: 10.1016/j.drugalcdep.2017.05.042 St HelenG. DempseyD.A. HavelC.M. JacobP. III BenowitzN.L. Impact of E-Liquid Flavors on Nicotine Intake and Pharmacology of E-Cigarettes Drug Alcohol Depend. 178 2017 391 398 10.1016/j.drugalcdep.2017.05.042 Open DOISearch in Google Scholar

17. St Helen, G., M. Shahid, S. Chu, and N.L. Benowitz: Impact of E-Liquid Flavors on E-Cigarette Vaping Behavior; Drug Alcohol Depend. 189 (2018) 42–48. DOI: 10.1016/j.drugalcdep.2018.04.032 St HelenG. ShahidM. ChuS. BenowitzN.L. Impact of E-Liquid Flavors on E-Cigarette Vaping Behavior Drug Alcohol Depend. 189 2018 42 48 10.1016/j.drugalcdep.2018.04.032 Open DOISearch in Google Scholar

18. Voos, N., D. Smith, L. Kaiser, M.C. Mahoney, C.M. Bradizza, L.T. Kozlowski, N.L. Benowitz, R.J. O’Connor, and M.L. Goniewicz: Effect of E-Cigarette Flavors on Nicotine Delivery and Puffing Topography: Results from a Randomized Clinical Trial of Daily Smokers; Psychopharmacology 237 (2020) 491–502. DOI: 10.1007/s00213-019-05386-x VoosN. SmithD. KaiserL. MahoneyM.C. BradizzaC.M. KozlowskiL.T. BenowitzN.L. O’ConnorR.J. GoniewiczM.L. Effect of E-Cigarette Flavors on Nicotine Delivery and Puffing Topography: Results from a Randomized Clinical Trial of Daily Smokers Psychopharmacology 237 2020 491 502 10.1007/s00213-019-05386-x Open DOISearch in Google Scholar

19. Keyser, B.M., K.S. Hong, P. DeLuca, T. Jin, B.A. Jones, P. Nelson, E. Schmidt, and E.K. Round: Part Two: An Unblinded, Parallel, Randomized Study to Assess Nicotine Pharmacokinetics of Four Vuse Solo ENDS Flavors in Smokers; Sci. Rep. 13 (2023) 8894. DOI: 10.1038/s41598-023-35439-3 KeyserB.M. HongK.S. DeLucaP. JinT. JonesB.A. NelsonP. SchmidtE. RoundE.K. Part Two: An Unblinded, Parallel, Randomized Study to Assess Nicotine Pharmacokinetics of Four Vuse Solo ENDS Flavors in Smokers Sci. Rep. 13 2023 8894 10.1038/s41598-023-35439-3 Open DOISearch in Google Scholar

20. Prasad, K., A. Gray, and L. Edward: Actual Use Puffing Topography and Mouth Level Exposure to Aerosol and Nicotine for an Evolving Series of Electronic Nicotine Delivery Systems; Int. J. Sci. Rep. 8 (2022) 366–376. DOI: 10.18203/issn.2454-2156.IntJSciRep20223033 PrasadK. GrayA. EdwardL. Actual Use Puffing Topography and Mouth Level Exposure to Aerosol and Nicotine for an Evolving Series of Electronic Nicotine Delivery Systems Int. J. Sci. Rep. 8 2022 366 376 10.18203/issn.2454-2156.IntJSciRep20223033 Open DOISearch in Google Scholar

21. McAdam, K., P. Davis, L. Ashmore, D. Eaton, B. Jakaj, A. Eldridge, and C. Liu: Influence of Machine-Based Puffing Parameters on Aerosol and Smoke Emissions from Next Generation Nicotine Inhalation Products; Reg. Toxicol. Pharmacol. 101 (2019) 156–165. DOI: 10.1016/j.yrtph.2018.11.006 McAdamK. DavisP. AshmoreL. EatonD. JakajB. EldridgeA. LiuC. Influence of Machine-Based Puffing Parameters on Aerosol and Smoke Emissions from Next Generation Nicotine Inhalation Products Reg. Toxicol. Pharmacol. 101 2019 156 165 10.1016/j.yrtph.2018.11.006 Open DOISearch in Google Scholar

22. Visser, W.F., E.J.Z. Krüsemann, W.N.M. Klerx, K. Boer, N. Weibolt, and R. Talhout: Improving the Analysis of E-Cigarette Emissions: Detecting Human “Dry Puff” Conditions in a Laboratory as Validated by a Panel of Experienced Vapers; Int. J. Environ. Res. Public Health 18 (2021) 11520. DOI: 10.3390/ijerph182111520 VisserW.F. KrüsemannE.J.Z. KlerxW.N.M. BoerK. WeiboltN. TalhoutR. Improving the Analysis of E-Cigarette Emissions: Detecting Human “Dry Puff” Conditions in a Laboratory as Validated by a Panel of Experienced Vapers Int. J. Environ. Res. Public Health 18 2021 11520 10.3390/ijerph182111520 Open DOISearch in Google Scholar

23. Gupta, A., R. Tayyarah, G. Gillman, C. Garner, and R. Stevens: Machine Vaping of Electronic Cigarettes - A Comparison of Puffing Regimes; Contrib. Tob. Nicotine Res. 30 (2021) 127–136. DOI: 10.2478/cttr-2021-0009 GuptaA. TayyarahR. GillmanG. GarnerC. StevensR. Machine Vaping of Electronic Cigarettes - A Comparison of Puffing Regimes Contrib. Tob. Nicotine Res. 30 2021 127 136 10.2478/cttr-2021-0009 Open DOISearch in Google Scholar

24. Dawkins, L., C. Kimber, M. Doig, C. Feyerabend, and O. Corcoran: Self-Titration by Experienced E-Cigarette Users: Blood Nicotine Delivery and Subjective Effects; Psychopharmacology 233 (2016) 2933–2941. DOI: 10.1007/s00213-016-4338-2 DawkinsL. KimberC. DoigM. FeyerabendC. CorcoranO. Self-Titration by Experienced E-Cigarette Users: Blood Nicotine Delivery and Subjective Effects Psychopharmacology 233 2016 2933 2941 10.1007/s00213-016-4338-2 Open DOISearch in Google Scholar

25. Hiler, M., A. Breland, T. Spindle, S. Maloney, T. Lipato, N. Karaoghlanian, A. Shihadeh, A. Lopez, C. Ramoa, and T. Eissenberg: Electronic Cigarette User Plasma Nicotine Concentration, Puff Topography, Heart Rate, and Subjective Effects: Influence of Liquid Nicotine Concentration and User Experience; Exp. Clin. Psychopharmacol. 25 (2017) 380–392. DOI: 10.1037/pha0000140 HilerM. BrelandA. SpindleT. MaloneyS. LipatoT. KaraoghlanianN. ShihadehA. LopezA. RamoaC. EissenbergT. Electronic Cigarette User Plasma Nicotine Concentration, Puff Topography, Heart Rate, and Subjective Effects: Influence of Liquid Nicotine Concentration and User Experience Exp. Clin. Psychopharmacol. 25 2017 380 392 10.1037/pha0000140 Open DOISearch in Google Scholar

26. Blank, M.D., J. Pearson, C.O. Cobb, N.J. Felicione, M.M. Hiler, T.R. Spindle, and A. Breland: What Factors Reliably Predict Electronic Cigarette Nicotine Delivery?; Tob. Control 29 (2020) 644–651. DOI: 10.1136/tobaccocontrol-2019-055193 BlankM.D. PearsonJ. CobbC.O. FelicioneN.J. HilerM.M. SpindleT.R. BrelandA. What Factors Reliably Predict Electronic Cigarette Nicotine Delivery? Tob. Control 29 2020 644 651 10.1136/tobaccocontrol-2019-055193 Open DOISearch in Google Scholar

27. Garg, M., R. Naidu, K. Iyer, and R. Jadhav: Bioequivalence of Two Different Nicotine Chewing Gum Formulations of Two Different Strengths (2 mg and 4 mg) in Indian Healthy Adult Human Male Smoker Subjects; J. Bioequiv. Availab. 08 (2016) 74–79. DOI: 10.4172/jbb.1000271 GargM. NaiduR. IyerK. JadhavR. Bioequivalence of Two Different Nicotine Chewing Gum Formulations of Two Different Strengths (2 mg and 4 mg) in Indian Healthy Adult Human Male Smoker Subjects J. Bioequiv. Availab. 08 2016 74 79 10.4172/jbb.1000271 Open DOISearch in Google Scholar

28. Heatherton, T.F., L.T. Kozlowski, R.C. Frecker, and K.-O. Fagerström: The Fagerström Test for Nicotine Dependence: a Revision of the Fagerström Tolerance Questionnaire; Br. J. Addict. 86 (1991) 1119–1127. DOI: 10.1111/j.1360-0443.1991.tb01879.x HeathertonT.F. KozlowskiL.T. FreckerR.C. FagerströmK.-O. The Fagerström Test for Nicotine Dependence: a Revision of the Fagerström Tolerance Questionnaire Br. J. Addict. 86 1991 1119 1127 10.1111/j.1360-0443.1991.tb01879.x Open DOISearch in Google Scholar

29. Fagerström, K.: Determinants of Tobacco Use and Renaming the FTND to the Fagerström Test for Cigarette Dependence; Nicotine Tob. Res. 14 (2012) 75–78. DOI: 10.1093/ntr/ntr137 FagerströmK. Determinants of Tobacco Use and Renaming the FTND to the Fagerström Test for Cigarette Dependence Nicotine Tob. Res. 14 2012 75 78 10.1093/ntr/ntr137 Open DOISearch in Google Scholar

30. Miller, E.I., H.-R.K. Norris, D.E. Rollins, S.T. Tiffany, and D.G. Wilkins: A Novel Validated Procedure for the Determination of Nicotine, Eight Nicotine Metabolites and Two Minor Tobacco Alkaloids in Human Plasma or Urine by Solid-Phase Extraction Coupled with Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry; J. Chromatogr. B 878 (2010) 725–737. DOI: 10.1016/j.jchromb.2009.12.018 MillerE.I. NorrisH.-R.K. RollinsD.E. TiffanyS.T. WilkinsD.G. A Novel Validated Procedure for the Determination of Nicotine, Eight Nicotine Metabolites and Two Minor Tobacco Alkaloids in Human Plasma or Urine by Solid-Phase Extraction Coupled with Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry J. Chromatogr. B 878 2010 725 737 10.1016/j.jchromb.2009.12.018 Open DOISearch in Google Scholar

31. Cappelleri, J.C., A.G. Bushmakin, C.L. Baker, E. Merikle, A.O. Olufade, and D.G. Gilbert: Confirmatory Factor Analyses and Reliability of the Modified Cigarette Evaluation Questionnaire; Addict. Behav. 32 (2007) 912–923. DOI: 10.1016/j.addbeh.2006.06.028 CappelleriJ.C. BushmakinA.G. BakerC.L. MerikleE. OlufadeA.O. GilbertD.G. Confirmatory Factor Analyses and Reliability of the Modified Cigarette Evaluation Questionnaire Addict. Behav. 32 2007 912 923 10.1016/j.addbeh.2006.06.028 Open DOISearch in Google Scholar

32. Farsalinos, K., K. Poulas, and V. Voudris: Changes in Puffing Topography and Nicotine Consumption Depending on the Power Setting of Electronic Cigarettes; Nicotine Tob. Res. 20 (2018) 993–997. DOI: 10.1093/ntr/ntx219 FarsalinosK. PoulasK. VoudrisV. Changes in Puffing Topography and Nicotine Consumption Depending on the Power Setting of Electronic Cigarettes Nicotine Tob. Res. 20 2018 993 997 10.1093/ntr/ntx219 Open DOISearch in Google Scholar

33. Liu, J., J. Rensch, J. Wang, X. Jin, A. Vansickel, J. Edmiston, and M. Sarkar: Nicotine Pharmacokinetics and Subjective Responses after Using Nicotine Pouches with Different Nicotine Levels Compared to Combustible Cigarettes and Moist Smokeless Tobacco in Adult Tobacco Users; Psychopharmacology 239 (2022) 2863–2873. DOI: 10.1007/s00213-022-06172-y LiuJ. RenschJ. WangJ. JinX. VansickelA. EdmistonJ. SarkarM. Nicotine Pharmacokinetics and Subjective Responses after Using Nicotine Pouches with Different Nicotine Levels Compared to Combustible Cigarettes and Moist Smokeless Tobacco in Adult Tobacco Users Psychopharmacology 239 2022 2863 2873 10.1007/s00213-022-06172-y Open DOISearch in Google Scholar

34. Patterson, F., N. Benowitz, P. Shields, V. Kaufmann, C. Jepson, P. Wileyto, S. Kucharski, and C. Lerman: Individual Differences in Nicotine Intake Per Cigarette; Cancer Epidemiol. Biomarkers Prev. 12 (2003) 468–471. PattersonF. BenowitzN. ShieldsP. KaufmannV. JepsonC. WileytoP. KucharskiS. LermanC. Individual Differences in Nicotine Intake Per Cigarette Cancer Epidemiol. Biomarkers Prev. 12 2003 468 471 Search in Google Scholar

35. Walele, T., G. Sharma, R. Savioz, C. Martin, and J. Williams: A Randomised, Crossover Study on an Electronic Vapour Product, a Nicotine Inhalator and a Conventional Cigarette. Part A: Pharmacokinetics; Regul. Toxicol. Pharmacol. 74 (2016) 187–192. DOI: 10.1016/j.yrtph.2015.12.003 WaleleT. SharmaG. SaviozR. MartinC. WilliamsJ. A Randomised, Crossover Study on an Electronic Vapour Product, a Nicotine Inhalator and a Conventional Cigarette. Part A: Pharmacokinetics Regul. Toxicol. Pharmacol. 74 2016 187 192 10.1016/j.yrtph.2015.12.003 Open DOISearch in Google Scholar

36. Stiles, M.F., L.R. Campbell, D.W. Graff, B.A. Jones, R.V. Fant, and J.E. Henningfield: Pharmacodynamic and Pharmacokinetic Assessment of Electronic Cigarettes, Combustible Cigarettes, and Nicotine Gum: Implications for Abuse Liability; Psychopharmacology 234 (2017) 2643–2655. DOI: 10.1007/s00213-017-4665-y StilesM.F. CampbellL.R. GraffD.W. JonesB.A. FantR.V. HenningfieldJ.E. Pharmacodynamic and Pharmacokinetic Assessment of Electronic Cigarettes, Combustible Cigarettes, and Nicotine Gum: Implications for Abuse Liability Psychopharmacology 234 2017 2643 2655 10.1007/s00213-017-4665-y Open DOISearch in Google Scholar

37. Stiles, M.F., L.R. Campbell, T. Jin, D.W. Graff, R.V. Fant, and J.E. Henningfield: Assessment of the Abuse Liability of Three Menthol Vuse Solo Electronic Cigarettes Relative to Combustible Cigarettes and Nicotine Gum; Psychopharmacology 235 (2018) 2077–2086. DOI: 10.1007/s00213-018-4904-x StilesM.F. CampbellL.R. JinT. GraffD.W. FantR.V. HenningfieldJ.E. Assessment of the Abuse Liability of Three Menthol Vuse Solo Electronic Cigarettes Relative to Combustible Cigarettes and Nicotine Gum Psychopharmacology 235 2018 2077 2086 10.1007/s00213-018-4904-x Open DOISearch in Google Scholar

38. O’Connell, G., J.D. Pritchard, C. Prue, J. Thompson, T. Verron, D. Graff, and T. Walele: A Randomised, Open-Label, Cross-over Clinical Study to Evaluate the Pharmacokinetic Profiles of Cigarettes and E-Cigarettes with Nicotine Salt Formulations in U.S. Adult Smokers; Intern. Emerg. Med. 14 (2019) 853–861. DOI: 10.1007/s11739-019-02025-3 O’ConnellG. PritchardJ.D. PrueC. ThompsonJ. VerronT. GraffD. WaleleT. A Randomised, Open-Label, Cross-over Clinical Study to Evaluate the Pharmacokinetic Profiles of Cigarettes and E-Cigarettes with Nicotine Salt Formulations in U.S. Adult Smokers Intern. Emerg. Med. 14 2019 853 861 10.1007/s11739-019-02025-3 Open DOISearch in Google Scholar

39. Ebajemito, J.K., M. McEwan, N. Gale, O.M. Camacho, G. Hardie, and C.J. Proctor: A Randomised Controlled Single-Centre Open-Label Pharmacokinetic Study to Examine Various Approaches of Nicotine Delivery Using Electronic Cigarettes; Sci. Rep. 10 (2020) 19980. DOI: 10.1038/s41598-020-76610-4 EbajemitoJ.K. McEwanM. GaleN. CamachoO.M. HardieG. ProctorC.J. A Randomised Controlled Single-Centre Open-Label Pharmacokinetic Study to Examine Various Approaches of Nicotine Delivery Using Electronic Cigarettes Sci. Rep. 10 2020 19980 10.1038/s41598-020-76610-4 Open DOISearch in Google Scholar

40. Behar, R.Z., M. Hua, and P. Talbot: Puffing Topography and Nicotine Intake of Electronic Cigarette Users; PLoS One 10 (2015) e0117222. DOI: 10.1371/journal.pone.0117222 BeharR.Z. HuaM. TalbotP. Puffing Topography and Nicotine Intake of Electronic Cigarette Users PLoS One 10 2015 e0117222 10.1371/journal.pone.0117222 Open DOISearch in Google Scholar

41. Vansickel, A.R., J.S. Edmiston, Q.W. Liang, C. Duhon, C. Connell, D. Bennett, and M. Sarkar: Characterization of Puff Topography of a Prototype Electronic Cigarette in Adult Exclusive Cigarette Smokers and Adult Exclusive Electronic Cigarette Users; Regul. Toxicol. Pharmacol. 98 (2018) 250–256. DOI: 10.1016/j.yrtph.2018.07.019 VansickelA.R. EdmistonJ.S. LiangQ.W. DuhonC. ConnellC. BennettD. SarkarM. Characterization of Puff Topography of a Prototype Electronic Cigarette in Adult Exclusive Cigarette Smokers and Adult Exclusive Electronic Cigarette Users Regul. Toxicol. Pharmacol. 98 2018 250 256 10.1016/j.yrtph.2018.07.019 Open DOISearch in Google Scholar

42. Gao, X., M. Fewx, J. Sprock, H. Jiang, Y. Gao, and Y. Liu: A Novel Puff Recording Electronic Nicotine Delivery System for Assessing Naturalistic Puff Topography and Nicotine Consumption During Ad Libitum Use: Ancillary Study; JMIR Form. Res. 7 (2023) e42544. DOI: 10.2196/42544 GaoX. FewxM. SprockJ. JiangH. GaoY. LiuY. A Novel Puff Recording Electronic Nicotine Delivery System for Assessing Naturalistic Puff Topography and Nicotine Consumption During Ad Libitum Use: Ancillary Study JMIR Form. Res. 7 2023 e42544 10.2196/42544 Open DOISearch in Google Scholar

43. Goldenson, N.I., I.M. Fearon, A.R. Buchhalter, and J.E. Henningfield: An Open-Label, Randomized, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers; Nicotine Tob. Res. 23 (2021) 947–955. DOI: 10.1093/ntr/ntab001 GoldensonN.I. FearonI.M. BuchhalterA.R. HenningfieldJ.E. An Open-Label, Randomized, Controlled, Crossover Study to Assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in Adult Smokers Nicotine Tob. Res. 23 2021 947 955 10.1093/ntr/ntab001 Open DOISearch in Google Scholar

44. Mallock, N., A. Rabenstein, S. Gernun, P. Laux, C. Hutzler, S. Karch, G. Koller, F. Henkler-Stephani, M.K. Parr, O. Pogarell, A. Luch, and T. Rüther: Nicotine Delivery and Relief of Craving after Consumption of European JUUL E-Cigarettes prior and after Pod Modification; Sci. Rep. 11 (2021) 12078. DOI: 10.1038/s41598-021-91593-6 MallockN. RabensteinA. GernunS. LauxP. HutzlerC. KarchS. KollerG. Henkler-StephaniF. ParrM.K. PogarellO. LuchA. RütherT. Nicotine Delivery and Relief of Craving after Consumption of European JUUL E-Cigarettes prior and after Pod Modification Sci. Rep. 11 2021 12078 10.1038/s41598-021-91593-6 Open DOISearch in Google Scholar

45. St.Helen, G., N. Nardone, N. Addo, D. Dempsey, C. Havel, P. Jacob III, and N.L. Benowitz: Differences in Nicotine Intake and Effects from Electronic and Combustible Cigarettes among Dual Users; Addiction 115 (2020) 757–767. DOI: 10.1111/add.14884 St.HelenG. NardoneN. AddoN. DempseyD. HavelC. JacobP. III BenowitzN.L. Differences in Nicotine Intake and Effects from Electronic and Combustible Cigarettes among Dual Users Addiction 115 2020 757 767 10.1111/add.14884 Open DOISearch in Google Scholar

46. Campbell, C., T. Jin, E.K. Round, E. Schmidt, P. Nelson, and S. Baxter: Part One: Abuse Liability of Vuse Solo (G2) Electronic Nicotine Delivery System Relative to Combustible Cigarettes and Nicotine Gum; Sci. Rep. 12 (2022) 22080. DOI: 10.1038/s41598-022-26417-2 CampbellC. JinT. RoundE.K. SchmidtE. NelsonP. BaxterS. Part One: Abuse Liability of Vuse Solo (G2) Electronic Nicotine Delivery System Relative to Combustible Cigarettes and Nicotine Gum Sci. Rep. 12 2022 22080 10.1038/s41598-022-26417-2 Open DOISearch in Google Scholar

47. Hanson, K., R. O’Connor, and D. Hatsukami: Measures for Assessing Subjective Effects of Potential Reduced-Exposure Products; Cancer Epidemiol. Biomarkers Prev. 18 (2009) 3209–3224. DOI: 10.1158/1055-9965.EPI-09-0971 HansonK. O’ConnorR. HatsukamiD. Measures for Assessing Subjective Effects of Potential Reduced-Exposure Products Cancer Epidemiol. Biomarkers Prev. 18 2009 3209 3224 10.1158/1055-9965.EPI-09-0971 Open DOISearch in Google Scholar

48. Carter, L.P., M.L. Stitzer, J.E. Henningfield, R.J. O’Connor, K.M. Cummings, and D.K. Hatsukami: Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products; Cancer Epidemiol. Biomarkers Prev. 18 (2009) 3241–3262. DOI: 10.1158/1055-9965.EPI-09-0948 CarterL.P. StitzerM.L. HenningfieldJ.E. O’ConnorR.J. CummingsK.M. HatsukamiD.K. Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products Cancer Epidemiol. Biomarkers Prev. 18 2009 3241 3262 10.1158/1055-9965.EPI-09-0948 Open DOISearch in Google Scholar

49. U.S. Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Center for Tobacco Products (CTP): Guidance for Industry - Modified Risk Tobacco Product Applications - Draft Guidance; DHHS, Rockville, MD, USA, 2012. Available at: https://www.fda.gov/media/83300/download (accessed June 2024) U.S. Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Center for Tobacco Products (CTP) Guidance for Industry - Modified Risk Tobacco Product Applications - Draft Guidance DHHS Rockville, MD, USA 2012 Available at: https://www.fda.gov/media/83300/download (accessed June 2024) Search in Google Scholar

50. Vansickel, A., S. Baxter, N. Sherwood, M. Kong, and L. Campbell: Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations; Nicotine Tob. Res. 24 (2022) 295–305. DOI: 10.1093/ntr/ntab183 VansickelA. BaxterS. SherwoodN. KongM. CampbellL. Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations Nicotine Tob. Res. 24 2022 295 305 10.1093/ntr/ntab183 Open DOISearch in Google Scholar

51. Hukkanen, J., P. Jacob III, and N.L. Benowitz: Metabolism and Disposition Kinetics of Nicotine; Pharmacol. Rev. 57 (2005) 79–115. DOI: 10.1124/pr.57.1.3 HukkanenJ. JacobP. III BenowitzN.L. Metabolism and Disposition Kinetics of Nicotine Pharmacol. Rev. 57 2005 79 115 10.1124/pr.57.1.3 Open DOISearch in Google Scholar

52. St.Helen, G., C. Havel, D.A. Dempsey, P. Jacob III, and N.L. Benowitz: Nicotine Delivery, Retention and Pharmacokinetics from Various Electronic Cigarettes; Addiction 111 (2016) 535–544. DOI: 10.1111/add.13183 St.HelenG. HavelC. DempseyD.A. JacobP. III BenowitzN.L. Nicotine Delivery, Retention and Pharmacokinetics from Various Electronic Cigarettes Addiction 111 2016 535 544 10.1111/add.13183 Open DOISearch in Google Scholar

53. Pagano, T., A.G. DiFrancesco, S.B. Smith, J. George, G. Wink, I. Rahman, and R.J. Robinson: Determination of Nicotine Content and Delivery in Disposable Electronic Cigarettes Available in the United States by Gas Chromatography-Mass Spectrometry; Nicotine Tob. Res. 18 (2016) 700–707. DOI: 10.1093/ntr/ntv120 PaganoT. DiFrancescoA.G. SmithS.B. GeorgeJ. WinkG. RahmanI. RobinsonR.J. Determination of Nicotine Content and Delivery in Disposable Electronic Cigarettes Available in the United States by Gas Chromatography-Mass Spectrometry Nicotine Tob. Res. 18 2016 700 707 10.1093/ntr/ntv120 Open DOISearch in Google Scholar

54. Omaiye, E.E., K.J. McWhirter, W. Luo, J.F. Pankow, and P. Talbot: High-Nicotine Electronic Cigarette Products: Toxicity of JUUL Fluids and Aerosols Correlates Strongly with Nicotine and Some Flavor Chemical Concentrations; Chem. Res. in Toxicol. 32 (2019) 1058–1069. DOI: 10.1021/acs.chemrestox.8b00381 OmaiyeE.E. McWhirterK.J. LuoW. PankowJ.F. TalbotP. High-Nicotine Electronic Cigarette Products: Toxicity of JUUL Fluids and Aerosols Correlates Strongly with Nicotine and Some Flavor Chemical Concentrations Chem. Res. in Toxicol. 32 2019 1058 1069 10.1021/acs.chemrestox.8b00381 Open DOISearch in Google Scholar